In dit gedeelte presenteren we gewoonlijk prognoses voor de omzet- en winstgroei op basis van de consensusramingen van professionele analisten om beleggers te helpen begrijpen in hoeverre het bedrijf in staat is winst te genereren. Maar omdat Hang Lung Group onvoldoende gegevens uit het verleden heeft verstrekt en geen analistenprognose heeft, kan de toekomstige winst niet betrouwbaar worden berekend door gegevens uit het verleden te extrapoleren of analistenprognoses te gebruiken.

Dit is een vrij zeldzame situatie, aangezien 97% van de bedrijven die worden gedekt door SimplyWall St wel financiële gegevens uit het verleden hebben.

Winst- en omzetgroeiprognoses

SEHK:10 - Toekomstschattingen van analisten en financiële gegevens uit het verleden (HKD Millions )
Datum	Inkomsten	Inkomsten	Vrije kasstroom	Geldmiddelen uit operationele activiteiten	Gem. Aantal analisten
6/30/2024	11,924	2,017	3,814	3,814	N/A
3/31/2024	11,466	2,414	3,918	3,918	N/A
12/31/2023	11,008	2,811	4,022	4,022	N/A
9/30/2023	10,941	2,886	4,394	4,394	N/A
6/30/2023	10,874	2,961	4,766	4,766	N/A
3/31/2023	10,937	2,840	4,605	4,605	N/A
12/31/2022	11,000	2,718	4,443	4,443	N/A
9/30/2022	11,191	2,619	4,665	4,665	N/A
6/30/2022	11,382	2,520	4,887	4,887	N/A
3/31/2022	11,144	2,555	3,965	3,965	N/A
12/31/2021	10,905	2,589	3,043	3,043	N/A
9/30/2021	10,547	2,076	2,668	2,668	N/A
6/30/2021	10,189	1,562	2,292	2,292	N/A
3/31/2021	9,712	11	3,027	3,027	N/A
12/31/2020	9,235	-1,541	3,761	3,761	N/A
9/30/2020	9,257	-14	4,380	4,380	N/A
6/30/2020	9,279	1,512	4,998	4,998	N/A
3/31/2020	9,449	4,164	5,348	5,348	N/A
12/31/2019	9,618	6,816	5,698	5,698	N/A
9/30/2019	9,484	6,387	5,353	5,353	N/A
6/30/2019	9,349	5,957	5,007	5,007	N/A
3/31/2019	9,900	5,621	5,556	5,556	N/A
12/31/2018	10,450	5,285	6,104	6,104	N/A
9/30/2018	10,729	5,620	5,942	5,942	N/A
6/30/2018	11,007	5,955	5,780	5,780	N/A
3/31/2018	11,501	5,635	N/A	7,309	N/A
12/31/2017	11,995	5,314	N/A	8,837	N/A
9/30/2017	12,887	4,817	N/A	9,666	N/A
6/30/2017	13,778	4,319	N/A	10,495	N/A
3/31/2017	13,778	4,016	N/A	8,762	N/A
12/31/2016	13,777	3,713	N/A	7,028	N/A
9/30/2016	12,625	3,468	N/A	6,696	N/A
6/30/2016	11,473	3,222	N/A	6,364	N/A
3/31/2016	10,629	3,217	N/A	6,182	N/A
12/31/2015	9,784	3,211	N/A	5,999	N/A
9/30/2015	13,905	4,878	N/A	9,904	N/A
6/30/2015	18,025	6,544	N/A	13,809	N/A
3/31/2015	17,993	6,685	N/A	14,632	N/A
12/31/2014	17,961	6,825	N/A	15,454	N/A
9/30/2014	14,654	5,838	N/A	11,493	N/A
6/30/2014	11,346	4,851	N/A	7,531	N/A
3/31/2014	10,756	4,704	N/A	6,352	N/A
12/31/2013	10,165	4,557	N/A	5,172	N/A

Toekomstige groeivoorspellingen analisten

Verdiensten versus spaarpercentage: Er zijn onvoldoende gegevens om te bepalen of de verwachte winstgroei van 10 boven de spaarquote ( 2.3% ) ligt.

Winst versus markt: Er zijn onvoldoende gegevens om te bepalen of de winst van 10 naar verwachting sneller zal groeien dan de markt Hong Kong

Hoge groeiwinsten: Er zijn onvoldoende gegevens om te bepalen of de winst van 10 naar verwachting de komende 3 jaar aanzienlijk zal groeien.

Omzet versus markt: Er zijn onvoldoende gegevens om te bepalen of de omzet van 10 naar verwachting sneller zal groeien dan de markt Hong Kong.

Hoge groei-inkomsten: Er zijn onvoldoende gegevens om te bepalen of de omzet van 10 naar verwachting sneller zal groeien dan 20% per jaar.

Groeiprognoses winst per aandeel

Toekomstig rendement op eigen vermogen

Toekomstige ROE: Onvoldoende gegevens om te bepalen of het rendement op eigen vermogen van 10 naar verwachting over 3 jaar hoog zal zijn

Hang Lung Group Toekomstige groei

Future criteriumcontroles 0/6

Belangrijke informatie

Recente toekomstige groei-updates

Recent updates

Investor sentiment improves as stock rises 17%

Investors Can Find Comfort In Hang Lung Group's (HKG:10) Earnings Quality

First half 2024 earnings released: EPS: HK$0.65 (vs HK$1.24 in 1H 2023)

Executive Chair of the Board recently bought HK$504k worth of stock

Executive Chair of the Board recently bought HK$334k worth of stock

Upcoming dividend of HK$0.21 per share

First half 2024 earnings released: EPS: HK$0.65 (vs HK$1.24 in 1H 2023)

Hang Lung Group Limited to Report First Half, 2024 Results on Jul 30, 2024

Hang Lung Group Limited Announces Audit Committee Changes, Effective July 1, 2024

Upcoming dividend of HK$0.65 per share

Full year 2023 earnings released: EPS: HK$2.06 (vs HK$2.00 in FY 2022)

Hang Lung Group (HKG:10) Takes On Some Risk With Its Use Of Debt

Executive Vice Chair of the Board recently bought HK$941k worth of stock

Hang Lung Group (HKG:10) Is Due To Pay A Dividend Of HK$0.65

Final dividend of HK$0.65 announced

Full year 2023 earnings released: EPS: HK$2.06 (vs HK$2.00 in FY 2022)

Hang Lung Properties Limited and Hang Lung Group Limited Announce Retirement of Mr. Ronnie Chichung Chan as the Chair, an Executive Director, and the Chair of Executive Committees, with Effect from April 26, 2024

Hang Lung Group Limited Appoints Ms. May Siew Boi Tan as an Independent Non-Executive Director, with Effect from March 20, 2024

Hang Lung Group Limited to Report Fiscal Year 2023 Results on Jan 30, 2024

Investors Continue Waiting On Sidelines For Hang Lung Group Limited (HKG:10)

Hang Lung Group (HKG:10) Takes On Some Risk With Its Use Of Debt

Hang Lung Group (HKG:10) Has Announced A Dividend Of HK$0.21

Upcoming dividend of HK$0.21 per share at 7.8% yield

Hang Lung Group (HKG:10) Is Paying Out A Dividend Of HK$0.21

CEO & Executive Director recently bought HK$542k worth of stock

Hang Lung Group (HKG:10) Will Pay A Dividend Of HK$0.21

First half 2023 earnings released: EPS: HK$1.24 (vs HK$1.06 in 1H 2022)

Hang Lung Group Limited Announces Interim Dividend for the Six Months Ended 30 June 2023, Payable on 29 September 2023

Hang Lung Group Limited to Report First Half, 2023 Results on Jul 31, 2023

These 4 Measures Indicate That Hang Lung Group (HKG:10) Is Using Debt Extensively

Upcoming dividend of HK$0.65 per share at 6.3% yield

Full year 2022 earnings released: EPS: HK$2.00 (vs HK$1.90 in FY 2021)

Hang Lung Group (HKG:10) Is Due To Pay A Dividend Of HK$0.65

Hang Lung Group (HKG:10) Is Paying Out A Dividend Of HK$0.65

Hang Lung Group Limited Proposes Final Dividend for the Year Ended 31 December 2022, Payable on 19 May 2023

Full year 2022 earnings released: EPS: HK$2.00 (vs HK$1.90 in FY 2021)

Less than half of directors are independent

Does Hang Lung Group (HKG:10) Have A Healthy Balance Sheet?

First half 2022 earnings released: EPS: HK$1.06 (vs HK$1.11 in 1H 2021)

Upcoming dividend of HK$0.21 per share

CEO & Executive Director recently bought HK$678k worth of stock

Hang Lung Group (HKG:10) Is Due To Pay A Dividend Of HK$0.21

Hang Lung Group Limited Announces Interim Dividend for the Six Months Ended 30 June 2022, Payable on 29 September 2022

First half 2022 earnings released

Hang Lung Group Limited to Report First Half, 2022 Results on Jul 28, 2022

Calculating The Intrinsic Value Of Hang Lung Group Limited (HKG:10)

Hang Lung Group Limited Approves Final Dividend

Less than half of directors are independent

Does Hang Lung Group (HKG:10) Have A Healthy Balance Sheet?

Now 20% undervalued after recent price drop

Hang Lung Group Limited Proposes Final Dividend for the Year Ended December 31, 2021, Payable on May 19, 2022

Full year 2021 earnings: EPS and revenues miss analyst expectations

Hang Lung Group Limited, Annual General Meeting, Apr 27, 2022

Is Hang Lung Group (HKG:10) A Risky Investment?

First half 2021 earnings released: EPS HK$1.11 (vs HK$1.17 loss in 1H 2020)

CEO & Executive Director recently bought HK$2.8m worth of stock

Upcoming dividend of HK$0.21 per share

CFO & Executive Director recently bought HK$562k worth of stock

CFO & Executive Director recently bought HK$417k worth of stock

First half 2021 earnings released: EPS HK$1.11 (vs HK$1.17 loss in 1H 2020)

Calculating The Fair Value Of Hang Lung Group Limited (HKG:10)

Director of General Counsel has left the company

Hang Lung Group Limited Declares Final Dividend for the Year 2020

Upcoming dividend of HK$0.63 per share

Shareholders May Be Wary Of Increasing Hang Lung Group Limited's (HKG:10) CEO Compensation Package

Full year 2020 earnings released: HK$1.13 loss per share (vs HK$5.01 profit in FY 2019)

These 4 Measures Indicate That Hang Lung Group (HKG:10) Is Using Debt Extensively

Are Dividend Investors Making A Mistake With Hang Lung Group Limited (HKG:10)?

Full year 2020 earnings released: HK$1.13 loss per share (vs HK$5.01 profit in FY 2019)

Hang Lung Group Limited, Annual General Meeting, Apr 30, 2021

What Kind Of Investors Own Most Of Hang Lung Group Limited (HKG:10)?

New 90-day high: HK$20.55

Would Shareholders Who Purchased Hang Lung Group's (HKG:10) Stock Three Years Be Happy With The Share price Today?

Hang Lung Group Limited to Report Fiscal Year 2020 Results on Jan 28, 2021

How Much Are Hang Lung Group Limited (HKG:10) Insiders Spending On Buying Shares?